Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2005
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182040 Benzamide derivatives
08/18/2005US20050182017 Immunostimulatory nucleic acid molecules
08/18/2005US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
08/18/2005US20050181072 Use of essential oils for combating gi tract infection by helicobacter-like organisms
08/18/2005US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
08/18/2005US20050180965 Heat-reversible composition treating hyposalia and asialia
08/18/2005US20050180963 Probiotic propionibacterium
08/18/2005US20050180959 Kinases involved in the regulation of energy homeostasis
08/18/2005US20050180929 Ozone treatment of root canals
08/18/2005CA2558877A1 Solifenacin succinate-containing composition
08/18/2005CA2555469A1 Use of relaxin-3 for promoting food intake, increasing body weight gain, increasing fat weight and for others
08/18/2005CA2555316A1 Combined pharmaceutical composition
08/18/2005CA2555304A1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
08/18/2005CA2554683A1 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
08/18/2005CA2554260A1 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
08/18/2005CA2554091A1 Prodrug comprising 5-aminosalicylate glycoside
08/18/2005CA2554030A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
08/18/2005CA2547843A1 Composition comprising polymeric material and uses thereof
08/17/2005EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation
08/17/2005EP1563843A1 Botulinum toxins for treating various disorders and associated pain
08/17/2005EP1563842A1 Simarouba amara and/or Momordica charantia extracts for the treatment of coccidiosis in poultry
08/17/2005EP1563835A1 Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses
08/17/2005EP1562615A1 Oral and dental composition
08/17/2005EP1562614A1 High affinity receptors for helicobacter pylori and use thereof
08/17/2005EP1562572A2 Pharmaceutical solutions of modafinil compounds
08/17/2005EP1436380B1 Composition comprising a lactobacillus strain and uses thereof
08/17/2005EP1429617A4 Methods for sterilizing preparations of digestive enzymes
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005EP1315496B1 The treatment of inflammatory disorders
08/17/2005EP1294372B1 Dry powder formulation comprising racecadotril
08/17/2005EP1285271B1 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005EP1023445B1 Cadherin derived growth factor and the application thereof
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005EP0837880B1 Enamel matrix related polypeptide
08/17/2005EP0835128B1 Use of il-11 to treat inflammation
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656125A Extraction of unmilled psyllium
08/17/2005CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656096A Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656091A Tetrahydropyran derivatives
08/17/2005CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656070A Melanocortin receptor ligands
08/17/2005CN1655809A Compositions and methods for treating and preventing necrosis
08/17/2005CN1655807A Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition
08/17/2005CN1655805A Chewable compositions containing a gel-forming extract of psyllium
08/17/2005CN1655797A Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655784A Use of compounds that are effective as selective opiate receptor modulators
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655776A Anti-constipation composition
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
08/17/2005CN1655761A Modified release pharmaceutical formulation
08/17/2005CN1655675A Combination therapy using trefoil peptides
08/17/2005CN1654066A Kidney-nourishing yang-strengthening medicine
08/17/2005CN1654064A Chinese medicinal composition for treating respiratory illness and digestive illness
08/17/2005CN1654063A Chinese medicinal composition for treating irritable bowel syndrome and its preparation method
08/17/2005CN1654057A Chinese medicine composition for treating acute cholecystitis and preparing method thereof
08/17/2005CN1654056A Chinese medicine composition for peridentitis and preparing method thereof
08/17/2005CN1654053A Chinese medicinal tonifying wine with kidney tonifying, qi sooting, kidney invigorating, blood benefiting, kidney nourishing, essence benefiting functions
08/17/2005CN1654052A Chinese medicinal tonifying wine with kidney warming, yang activating, cold dispersing, pain relieving, blood activating, qi circulation promoting functions
08/17/2005CN1654051A Chinese medicinal tonifying wine capable of chest oppression soothing, qi regulating, stomach regulating, tendons relaxing and activating functions
08/17/2005CN1654049A Chinese medicinal tonifying wine for preventing and treating pestilence, cholera, abdominal pain and stomach stuff
08/17/2005CN1654048A Chinese medicinal tonifying wine112
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1214817C Coupling factor 6 inhibitor and potentiator and use thereof
08/17/2005CN1214809C Drip pills for curing aphtha and its preparing method
08/17/2005CN1214807C Toxicant-elimination medicine
08/17/2005CN1214800C Shanbao Oil (contg. plant seed oil and insect power) capsule
08/17/2005CN1214790C Method for preparing isoxazole substituted composition for treating inflammation
08/17/2005CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
08/16/2005US6930188 Stable hydrate of a muscarinic receptor antagonist
08/16/2005US6930123 Benz(f)indole compounds useful for Inflammatory Diseases
08/16/2005US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals
08/16/2005US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6930101 Thiazolopyrimidines useful as TNFα inhibitors
08/16/2005US6930100 Phosphate prodrugs of fluoroxindoles
08/16/2005US6930093 [1- beta -D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, [1- beta -ribofuranosyl-1H-1,2,4-triazole-3-amidine,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-amidine
08/16/2005US6929793 Nutritional composition for treating an immune condition
08/16/2005US6929790 Containing a zinc compound containing free available zinc ion and at least one stabilized oxidation potential raising compound, stored separately and mixed prior to using the oral composition.